Water	O
pipe	O
(	O
Shisha	O
,	O
Hookah	O
,	O
Arghile	O
)	O
Smoking	O
and	O
Secondhand	B:C0375734
Tobacco	I:C0375734
Smoke	I:C0375734
Effects	O
on	O
CYP1A2	O
and	O
CYP2A6	O
Phenotypes	O
as	O
Measured	O
by	O
Caffeine	O
Urine	I:C0042014
Test	I:C0042014
.	O

Water	O
pipe	O
(	O
Shisha	O
,	O
Hookah	O
,	O
Arghile	O
)	O
Smoking	O
and	O
Secondhand	O
Tobacco	I:C0375734
Smoke	I:C0375734
Effects	O
on	O
CYP1A2	B:C1620185
and	O
CYP2A6	O
Phenotypes	O
as	O
Measured	O
by	O
Caffeine	O
Urine	I:C0042014
Test	I:C0042014
.	O

Water	O
pipe	O
(	O
Shisha	O
,	O
Hookah	O
,	O
Arghile	O
)	O
Smoking	O
and	O
Secondhand	O
Tobacco	I:C0375734
Smoke	I:C0375734
Effects	O
on	O
CYP1A2	O
and	O
CYP2A6	B:C3884187
Phenotypes	O
as	O
Measured	O
by	O
Caffeine	O
Urine	I:C0042014
Test	I:C0042014
.	O

Water	O
pipe	O
(	O
Shisha	O
,	O
Hookah	O
,	O
Arghile	O
)	O
Smoking	O
and	O
Secondhand	O
Tobacco	I:C0375734
Smoke	I:C0375734
Effects	O
on	O
CYP1A2	O
and	O
CYP2A6	O
Phenotypes	O
as	O
Measured	O
by	O
Caffeine	B:C0042014
Urine	I:C0042014
Test	I:C0042014
.	O

Public	B:C0085098
policies	I:C0085098
to	O
stop	O
or	O
reduce	O
cigarette	O
smoking	O
and	O
exposure	O
to	O
secondhand	O
smoke	I:C0375734
and	O
associated	O
diseases	I:C0243083
have	O
yielded	O
successful	O
results	O
over	O
the	O
past	O
decade	O
.	O

Public	O
policies	I:C0085098
to	O
stop	O
or	O
reduce	O
cigarette	O
smoking	O
and	O
exposure	O
to	O
secondhand	B:C0375734
smoke	I:C0375734
and	O
associated	O
diseases	I:C0243083
have	O
yielded	O
successful	O
results	O
over	O
the	O
past	O
decade	O
.	O

Public	O
policies	I:C0085098
to	O
stop	O
or	O
reduce	O
cigarette	O
smoking	O
and	O
exposure	O
to	O
secondhand	O
smoke	I:C0375734
and	O
associated	B:C0243083
diseases	I:C0243083
have	O
yielded	O
successful	O
results	O
over	O
the	O
past	O
decade	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pipe	O
smoking	O
on	O
cytochrome	B:C1149063
P450	I:C1149063
(	I:C1149063
CYP450	I:C1149063
)	I:C1149063
activities	I:C1149063
and	O
drug	O
interaction	I:C0687133
potential	O
in	O
humans	O
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
secondhand	O
smoke	I:C0375734
on	O
drug	O
metabolism	I:C0683140
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pipe	O
smoking	O
on	O
cytochrome	O
P450	I:C1149063
(	I:C1149063
CYP450	I:C1149063
)	I:C1149063
activities	I:C1149063
and	O
drug	B:C0687133
interaction	I:C0687133
potential	O
in	O
humans	O
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
secondhand	O
smoke	I:C0375734
on	O
drug	O
metabolism	I:C0683140
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pipe	O
smoking	O
on	O
cytochrome	O
P450	I:C1149063
(	I:C1149063
CYP450	I:C1149063
)	I:C1149063
activities	I:C1149063
and	O
drug	O
interaction	I:C0687133
potential	O
in	O
humans	B:C0086418
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
secondhand	O
smoke	I:C0375734
on	O
drug	O
metabolism	I:C0683140
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pipe	O
smoking	O
on	O
cytochrome	O
P450	I:C1149063
(	I:C1149063
CYP450	I:C1149063
)	I:C1149063
activities	I:C1149063
and	O
drug	O
interaction	I:C0687133
potential	O
in	O
humans	O
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
secondhand	B:C0375734
smoke	I:C0375734
on	O
drug	O
metabolism	I:C0683140
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
no	O
study	O
to	O
date	O
has	O
evaluated	O
the	O
effects	O
of	O
water	O
pipe	O
smoking	O
on	O
cytochrome	O
P450	I:C1149063
(	I:C1149063
CYP450	I:C1149063
)	I:C1149063
activities	I:C1149063
and	O
drug	O
interaction	I:C0687133
potential	O
in	O
humans	O
,	O
whereas	O
only	O
limited	O
information	O
is	O
available	O
on	O
the	O
impact	O
of	O
secondhand	O
smoke	I:C0375734
on	O
drug	B:C0683140
metabolism	I:C0683140
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	B:C1708335
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	O
enzyme	O
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	B:C0375734
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	O
enzyme	O
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	B:C0027361
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	O
enzyme	O
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	B:C1620185
and	O
CYP2A6	O
enzyme	O
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	B:C3884187
enzyme	O
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	O
enzyme	B:C0243102
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	O
enzyme	O
activities	I:C0243102
in	B:C1515655
vivo	I:C1515655
using	O
caffeine	O
urine	I:C0042014
test	I:C0042014
.	O

In	O
a	O
sample	O
of	O
99	O
healthy	O
volunteers	I:C1708335
(	O
28	O
water	O
pipe	O
smokers	O
,	O
30	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
exposed	O
persons	O
,	O
and	O
41	O
controls	O
)	O
,	O
we	O
systematically	O
compared	O
CYP1A2	O
and	O
CYP2A6	O
enzyme	O
activities	I:C0243102
in	O
vivo	I:C1515655
using	O
caffeine	B:C0042014
urine	I:C0042014
test	I:C0042014
.	O

The	O
median	O
self	B:C2700446
-	I:C2700446
reported	I:C2700446
duration	O
of	O
water	O
pipe	O
smoking	O
was	O
7.5	O
h	O
/	O
week	O
and	O
3	O
years	O
of	O
exposure	O
in	O
total	O
.	O

The	O
secondhand	B:C0375734
smoke	I:C0375734
group	O
had	O
a	O
median	O
of	O
14	O
h	O
of	O
self	O
-	I:C2700446
reported	I:C2700446
weekly	O
exposure	O
to	O
tobacco	O
smoke	I:C0439994
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	O
/	O
hour	O
for	O
a	O
total	O
of	O
3.5	O
years	O
(	O
median	O
)	O
.	O

The	O
secondhand	O
smoke	I:C0375734
group	B:C1257890
had	O
a	O
median	O
of	O
14	O
h	O
of	O
self	O
-	I:C2700446
reported	I:C2700446
weekly	O
exposure	O
to	O
tobacco	O
smoke	I:C0439994
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	O
/	O
hour	O
for	O
a	O
total	O
of	O
3.5	O
years	O
(	O
median	O
)	O
.	O

The	O
secondhand	O
smoke	I:C0375734
group	O
had	O
a	O
median	O
of	O
14	O
h	O
of	O
self	B:C2700446
-	I:C2700446
reported	I:C2700446
weekly	O
exposure	O
to	O
tobacco	O
smoke	I:C0439994
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	O
/	O
hour	O
for	O
a	O
total	O
of	O
3.5	O
years	O
(	O
median	O
)	O
.	O

The	O
secondhand	O
smoke	I:C0375734
group	O
had	O
a	O
median	O
of	O
14	O
h	O
of	O
self	O
-	I:C2700446
reported	I:C2700446
weekly	O
exposure	O
to	O
tobacco	B:C0439994
smoke	I:C0439994
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	O
/	O
hour	O
for	O
a	O
total	O
of	O
3.5	O
years	O
(	O
median	O
)	O
.	O

The	O
secondhand	O
smoke	I:C0375734
group	O
had	O
a	O
median	O
of	O
14	O
h	O
of	O
self	O
-	I:C2700446
reported	I:C2700446
weekly	O
exposure	O
to	O
tobacco	O
smoke	I:C0439994
indoor	O
where	O
a	O
minimum	O
of	O
five	O
cigarettes	O
were	O
smoked	B:C0239059
/	O
hour	O
for	O
a	O
total	O
of	O
3.5	O
years	O
(	O
median	O
)	O
.	O

Analysis	B:C0936012
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
CYP1A2	O
and	O
CYP2A6	O
activities	O
among	O
the	O
three	O
study	O
groups	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Analysis	O
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
CYP1A2	B:C1620185
and	O
CYP2A6	O
activities	O
among	O
the	O
three	O
study	O
groups	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Analysis	O
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
CYP1A2	O
and	O
CYP2A6	B:C3884187
activities	O
among	O
the	O
three	O
study	O
groups	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Analysis	O
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
CYP1A2	O
and	O
CYP2A6	O
activities	B:C0243102
among	O
the	O
three	O
study	O
groups	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Analysis	O
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
CYP1A2	O
and	O
CYP2A6	O
activities	O
among	O
the	O
three	O
study	B:C2603343
groups	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Analysis	O
of	O
variance	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
CYP1A2	O
and	O
CYP2A6	O
activities	O
among	O
the	O
three	O
study	O
groups	B:C1257890
(	O
p	O
>	O
0.05	O
)	O
.	O

Nor	O
was	O
there	O
a	O
significant	O
association	O
between	O
the	O
extent	O
of	O
water	O
pipe	O
or	O
secondhand	B:C0375734
smoke	I:C0375734
exposure	O
and	O
the	O
CYP1A2	O
and	O
CYP2A6	O
activities	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Nor	O
was	O
there	O
a	O
significant	O
association	O
between	O
the	O
extent	O
of	O
water	O
pipe	O
or	O
secondhand	O
smoke	I:C0375734
exposure	O
and	O
the	O
CYP1A2	B:C1620185
and	O
CYP2A6	O
activities	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Nor	O
was	O
there	O
a	O
significant	O
association	O
between	O
the	O
extent	O
of	O
water	O
pipe	O
or	O
secondhand	O
smoke	I:C0375734
exposure	O
and	O
the	O
CYP1A2	O
and	O
CYP2A6	B:C3884187
activities	O
(	O
p	O
>	O
0.05	O
)	O
.	O

Nor	O
was	O
there	O
a	O
significant	O
association	O
between	O
the	O
extent	O
of	O
water	O
pipe	O
or	O
secondhand	O
smoke	I:C0375734
exposure	O
and	O
the	O
CYP1A2	O
and	O
CYP2A6	O
activities	B:C0243102
(	O
p	O
>	O
0.05	O
)	O
.	O

Further	O
analysis	B:C0936012
in	O
a	O
subsample	O
with	O
smoke	O
exposure	O
more	O
than	O
the	O
median	O
values	O
also	O
did	O
not	O
reveal	O
a	O
significant	O
difference	O
from	O
the	O
controls	O
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	B:C0375734
smoke	I:C0375734
on	O
in	O
vivo	I:C1515655
activities	O
of	O
these	O
two	O
drug	O
metabolism	I:C0683140
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	O
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	I:C0239059
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	I:C0375734
on	O
in	B:C1515655
vivo	I:C1515655
activities	O
of	O
these	O
two	O
drug	O
metabolism	I:C0683140
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	O
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	I:C0239059
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	I:C0375734
on	O
in	O
vivo	I:C1515655
activities	B:C0243102
of	O
these	O
two	O
drug	O
metabolism	I:C0683140
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	O
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	I:C0239059
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	I:C0375734
on	O
in	O
vivo	I:C1515655
activities	O
of	O
these	O
two	O
drug	B:C0683140
metabolism	I:C0683140
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	O
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	I:C0239059
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	I:C0375734
on	O
in	O
vivo	I:C1515655
activities	O
of	O
these	O
two	O
drug	O
metabolism	I:C0683140
pathways	B:C1704259
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	O
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	I:C0239059
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	I:C0375734
on	O
in	O
vivo	I:C1515655
activities	O
of	O
these	O
two	O
drug	O
metabolism	I:C0683140
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	B:C0683140
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	O
smoke	I:C0239059
.	O

Although	O
we	O
do	O
not	O
rule	O
out	O
an	O
appreciable	O
possible	O
impact	O
of	O
water	O
pipe	O
smoke	O
and	O
secondhand	O
smoke	I:C0375734
on	O
in	O
vivo	I:C1515655
activities	O
of	O
these	O
two	O
drug	O
metabolism	I:C0683140
pathways	O
,	O
variability	O
in	O
smoke	O
constituents	O
from	O
different	O
tobacco	O
consumption	O
methods	O
(	O
e.g.	O
,	O
water	O
pipe	O
)	O
might	O
affect	O
drug	O
metabolism	I:C0683140
in	O
ways	O
that	O
might	O
differ	O
from	O
that	O
of	O
cigarette	B:C0239059
smoke	I:C0239059
.	O

Further	O
studies	B:C2603343
in	O
larger	O
prospective	O
samples	O
are	O
recommended	O
to	O
evaluate	O
water	O
pipe	O
and	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
effects	O
on	O
cytochrome	O
P450	I:C0010762
function	O
,	O
particularly	O
at	O
higher	O
smoke	O
exposure	O
conditions	O
.	O

Further	O
studies	O
in	O
larger	O
prospective	O
samples	O
are	O
recommended	O
to	O
evaluate	O
water	O
pipe	O
and	O
secondhand	B:C0375734
tobacco	I:C0375734
smoke	I:C0375734
effects	O
on	O
cytochrome	O
P450	I:C0010762
function	O
,	O
particularly	O
at	O
higher	O
smoke	O
exposure	O
conditions	O
.	O

Further	O
studies	O
in	O
larger	O
prospective	O
samples	O
are	O
recommended	O
to	O
evaluate	O
water	O
pipe	O
and	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
effects	O
on	O
cytochrome	B:C0010762
P450	I:C0010762
function	O
,	O
particularly	O
at	O
higher	O
smoke	O
exposure	O
conditions	O
.	O

Further	O
studies	O
in	O
larger	O
prospective	O
samples	O
are	O
recommended	O
to	O
evaluate	O
water	O
pipe	O
and	O
secondhand	O
tobacco	I:C0375734
smoke	I:C0375734
effects	O
on	O
cytochrome	O
P450	I:C0010762
function	O
,	O
particularly	O
at	O
higher	O
smoke	B:C0439994
exposure	O
conditions	O
.	O

